Inhibitors of hepatitis C virus RNA-dependent RNA polymerase, and compositions and treatments using the same
US7622605B2 · kind B2 · utility
1Cited by
16References
3Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 6, 2006 |
| Grant date | Nov 24, 2009 |
| Priority date | — |
| Expiry date | Feb 21, 2027 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D487/04
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The present invention provides compounds of formula (4), and their pharmaceutically acceptable salts and solvates, which are useful as inhibitors of the Hepatitis C virus (HCV) polymerase enzyme and are also useful for the treatment of HCV infections in HCV-infected mammals. The present invention also provides pharmaceutical compositions comprising compounds of formula (4), their pharmaceutically acceptable salts and solvates. Furthermore, the present invention provides intermediate compounds and methods useful in the preparation of compounds of formula (4).
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.